The new generation of antipsychotic drugs

C. A. Tamminga, A. C. Lahti

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

New neuroleptic drugs are being developed for the treatment of schizophrenia and other psychoses. Clozapine and risperidone are available for general use. Sertindole and olanzapine are nearing release. Seroquel and ziprazidone are in the final stages of study. This generation of drugs will provide advantages in the area of lower motor side effects and probably in improved negative symptom treatment.

Original languageEnglish (US)
Pages (from-to)73-76
Number of pages4
JournalInternational Clinical Psychopharmacology
Volume11
Issue numberSUPPL. 2
DOIs
StatePublished - 1996

Fingerprint

olanzapine
Risperidone
Clozapine
Motor Cortex
Psychotic Disorders
Antipsychotic Agents
Schizophrenia
Pharmaceutical Preparations
sertindole
Quetiapine Fumarate
ziprasidone

Keywords

  • Clinical response
  • Neuroleptics
  • New antipsychotics
  • Olanzapine
  • Seroquel
  • Sertindole
  • Ziprazidone

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

The new generation of antipsychotic drugs. / Tamminga, C. A.; Lahti, A. C.

In: International Clinical Psychopharmacology, Vol. 11, No. SUPPL. 2, 1996, p. 73-76.

Research output: Contribution to journalArticle

Tamminga, C. A. ; Lahti, A. C. / The new generation of antipsychotic drugs. In: International Clinical Psychopharmacology. 1996 ; Vol. 11, No. SUPPL. 2. pp. 73-76.
@article{c6045e5c509e40308755d732a9ce36d9,
title = "The new generation of antipsychotic drugs",
abstract = "New neuroleptic drugs are being developed for the treatment of schizophrenia and other psychoses. Clozapine and risperidone are available for general use. Sertindole and olanzapine are nearing release. Seroquel and ziprazidone are in the final stages of study. This generation of drugs will provide advantages in the area of lower motor side effects and probably in improved negative symptom treatment.",
keywords = "Clinical response, Neuroleptics, New antipsychotics, Olanzapine, Seroquel, Sertindole, Ziprazidone",
author = "Tamminga, {C. A.} and Lahti, {A. C.}",
year = "1996",
doi = "10.1097/00004850-199605002-00012",
language = "English (US)",
volume = "11",
pages = "73--76",
journal = "International Clinical Psychopharmacology",
issn = "0268-1315",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 2",

}

TY - JOUR

T1 - The new generation of antipsychotic drugs

AU - Tamminga, C. A.

AU - Lahti, A. C.

PY - 1996

Y1 - 1996

N2 - New neuroleptic drugs are being developed for the treatment of schizophrenia and other psychoses. Clozapine and risperidone are available for general use. Sertindole and olanzapine are nearing release. Seroquel and ziprazidone are in the final stages of study. This generation of drugs will provide advantages in the area of lower motor side effects and probably in improved negative symptom treatment.

AB - New neuroleptic drugs are being developed for the treatment of schizophrenia and other psychoses. Clozapine and risperidone are available for general use. Sertindole and olanzapine are nearing release. Seroquel and ziprazidone are in the final stages of study. This generation of drugs will provide advantages in the area of lower motor side effects and probably in improved negative symptom treatment.

KW - Clinical response

KW - Neuroleptics

KW - New antipsychotics

KW - Olanzapine

KW - Seroquel

KW - Sertindole

KW - Ziprazidone

UR - http://www.scopus.com/inward/record.url?scp=0029890025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029890025&partnerID=8YFLogxK

U2 - 10.1097/00004850-199605002-00012

DO - 10.1097/00004850-199605002-00012

M3 - Article

C2 - 8803664

AN - SCOPUS:0029890025

VL - 11

SP - 73

EP - 76

JO - International Clinical Psychopharmacology

JF - International Clinical Psychopharmacology

SN - 0268-1315

IS - SUPPL. 2

ER -